NCT05338619 2023-09-01
PLATINUM
Korea University Guro Hospital
Phase 2 Unknown
Clinical Trials
5 trialsNCT06020989 2023-09-01
CHAMELEON
Yonsei University
Phase 2 Unknown
NCT05701384 2023-01-27
Lazertinib 160mg in EGFR T790M NSCLC
Samsung Medical Center
Phase 2 Unknown
NCT05477615 2022-07-28
Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases
Seoul St. Mary's Hospital
Phase 2 Unknown
NCT05167851 2021-12-22
The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer
Yonsei University
Phase 2 Unknown